INTRODUCTION
Dihydrofolate reductase (EC 1.5.1.3) catalyses the NADPH-dependent reduction of dihydrofolate to tetrahydrofolate. Failure to reduce dihydrofolate causes depletion of active folate, with consequent cessation of DNA synthesis and, ultimately, cell death. Dihydrofolate reductase is of considerable pharmacological interest as the site of action of drugs such as trimethoprim and methotrexate Blakley, 1969) .
Although dihydrofolate reductases from Escherichia coli and several other bacterial species have been studied in depth, nothing is known about this enzyme in mycobacteria. These organisms are important because of the continuing prevalence of mycobacterial diseases such as tuberculosis and leprosy, and because of the limited range of antibiotics currently available to treat these infections. As a first step, we have purified and characterized the dihydrofolate reductase ofa saprophytic organism, Mycobacterium phlei. (30-80o% saturation). After the precipitate had been redissolved in standard buffer, it was fractionated on a Sephadex G-75 column (54 cm x 2.5 cm) previously equilibrated with standard buffer. The active fractions were pooled, and bovine serum albumin (1 mg/ml) was added to stabilize the enzyme. The solution was applied to a Blue Sepharose column (20 cm x 1.5 cm), which was then washed with the standard buffer until the A280 of the effluent was less than 0.02. The enzyme was eluted with 1 mM-dihydrofolate in the same buffer. Although no attempt was made to remove the dihydrofolate, all enzyme preparations were routinely tested for the presence of NADPH oxidase activity in the absence of added dihydrofolate; the purified enzyme showed no such activity. Inhibition studies The standard assay conditions were used with various concentrations of either trimethoprim or methotrexate. The assay mixture was normally left to stand for 5 min before the reaction was started by adding dihydrofolate; however, there was no indication that this period of preincubation had any significant effect.
Enzyme characterization
The Mr of the purified enzyme was determined by SDS/polyacrylamide-gel electrophoresis (Laemmli & Favre, 1973) . Isoelectric focusing was carried out in an LKB Multiphor apparatus fitted with a cooling system. Pre-prepared Ampholine polyacrylamide-gel plates (pH range 3.5-9.5) were purchased from LKB. Bands of dihydrofolate reductase activity were located on the gel by using the zymographic stain described by TennhammarEkman & Skold (1979) and Broad & Smith (1982) . The pH-dependence of enzyme activity was determined by using 0.1 M-sodium citrate, 0.1 M-potassium phosphate Vol. 235 and 25 mM-sodium borate buffers. Tris/HCl and sodium acetate buffers were found to cause an unacceptably high rate of enzyme-independent decline of absorbance.
RESULTS AND DISCUSSION
The results of a typical purification are shown in Table  1 . No value is quoted for the enzyme activity in the crude lysate since the presence of high levels of NADPH oxidase activity makes it impossible to assay the enzyme. This contaminating activity sometimes persisted through the (NH4)2SO4 fractionation as well. A similar problem was encountered by Amyes & Smith (1976) in the purification of a plasmid-mediated dihydrofolate reductase from E. coli. A further problem encountered was instability of the partially purified enzyme, after elution from Sephadex. The addition of glycerol or NADPH, reported previously to stabilize the enzyme from the E. coli plasmid R483 (Novak et al., 1983) , had no effect on the M. phlei dihydrofolate reductase. However, it was found that the use of bovine serum albumin (1 mg/ml) was effective in stabilizing the enzyme, since no loss of activity was seen after 3 weeks at -20°C or after 3.5 h at 45 'C.
A key step in the purification is the use of Blue Sepharose, which will bind many enzymes that use nucleotide cofactors; in the case of dihydrofolate reductase, specific elution from the column is obtained by the use of dihydrofolate as the eluting agent. This procedure resulted in a very high degree of purification with good recovery of enzyme, although only small amounts of protein could be obtained from each batch. The method is likely to be applicable to dihydrofolate reductases from other mycobacteria (or other sources) with only minor modifications; we have used the same procedure successfully with Mycobacterium smegmatis (results not shown).
When the purified enzyme was subjected to SDS/ polyacrylamide-gel electrophoresis, a single protein band was observed, corresponding to an Mr of 15000; this is less than the values of 21 000 and 17 900 observed for the dihydrofolate reductases from E. coli and Lactobacillus casei respectively (Chambers & Dunlap, 1979; Dann et al., 1976) . Isoelectric focusing showed the M. phlei enzyme to have a pI of 4.8, compared with the two bands at 4.4 and 4.0 obtained with the enzyme from E. coli (Broad & Smith, 1982) . In the absence of dihydrofolate, no bands were seen, indicating that no non-specific reactions had occurred. The pH-dependence of the activity of the enzyme (Fig. 1) is similar to that of the enzymes from E. coli, Staphylococcus aureus and Proteus vulgaris , with a maximum at pH 7.0.
Apparent Km values were obtained from doublereciprocal plots, giving values of 8.6 /LM for dihydrofolate and 35 4aM for NADPH. Ackermann-Potter plots (Ackermann & Potter, 1949) of the inhibition by trimethoprim or methotrexate gave straight lines passing through the origin (results not shown), indicating that the inhibition is reversible. Double-reciprocal plots also showed competitive inhibition. Dixon plots (Dixon & Webb, 1979) for both inhibitors are shown in Fig. 2 ; the lines were fitted by linear regression and the intercepts of the lines were determined algebraically. The mean Ki values derived from these intercepts were 0.9 /M for trimethoprim and 1.8 nm for methotrexate. These values are several orders of magnitude higher than those observed for the enzymes from E. coli (Baccanari & Joyner, 1981) and Neisseria gonorrhoeae (Baccanari & Tansik, 1984) , indicating a relatively weak binding of these competitive inhibitors to the M. phlei enzyme. The binding was, however, more rapid than that observed with the E. coli enzyme by Baccanari & Tansik (1984) Further studies of other mycrobacterial dihydrofolate reductases, especially that of the leprosy bacillus Mycobacterium leprae, will depend on the outcome of gene cloning work, and in particular on the identification of the gene in recombinant DNA libraries. The results reported here establish a baseline for such work and confirm that, although these enzymes are similar in many respects to that of E. coli, it should be possible to distinguish a cloned mycobacterial dihydrofolate reductase from the resident E. coli enzyme.
